El Hospital Universitario De Gran Canaria Dr. Negrin — Clinical Trial Site

165 Registered trials

68 Currently recruiting

Organisation

El Hospital Universitario De Gran Canaria Dr. Negrin

Location

Las Palmas De Gran Canaria, Spain

Identifier

ORG-100043578

Address

Barranco De La Ballena Sn, 35010, Spain

Departments

-
#2311:servicio de neurología
#2353: Servicio de dermatología
#3404: Cardiología
#40294: Dermatología
#7003: Hematologia y Transfusión
#7013:Dermatología
#7503: Servicio Dermatología
#9004:Dermatología
172418: Hematología
2604: Cardiology
2750; Dermatología
2806:Dermatología
2808: Cardiologia
2902: Hematology
3120: Cardiología
3503: Cardiologia
6079: Dermatology
6507: Dermatología
7209: Neurology
9009: Neurology
9256: Servicio Dermatología
9755; Dermatología
Alergología
Alergology
Allergology
Allergy
Analisis Clínicos
Cardiología
Cardiology
Cirugía
Clinical Haematology
Departamento de Neurología
Dermatología
Dermatology
Digestive
Digestive Department
Digestive Service
Digestive system
Digestivo
ES050A: Hematología
ES30002: Hematologia y Transfusión
Gastroenterología
Gastroenterology
Haematology
Haematology and Haemotherapy
Hematología
Hematology
Hematology Department
Hematology Service
Hosp. Gran Canaria Dr. Negrín_Cardiology service
Hosp. U Gran Canaria Dr. Negrín_Cardiologia
Hospital Universitario de Gran Canaria Doctor Negrín
Internal medicine- Infectious Disease Department
N/A
Neumología
Neurología
Neurology
Neurology department
Oncología Radioterápica
Oncology
Otorrinolaringología
Pneumology Service
Radiation Oncology
Radiotherapy oncology service
Research Unit, Chronic Pain Unit, Radiation Oncology Department
Respiratory medicine
Respiratoy Medicine
Restiratoy Medicine
Reumatología
Servicio de digestivo
Servicio de Aparato Digestivo
Servicio de Dermatología
Servicio de Digestivo
Servicio de Hematología
Servicio de Medicina Interna
Servicio de Neurologia
Surgery
Thoracic Oncology

Clinical trials at this site (165)

Search interface

Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma Under evaluation

2024-514991-41-01 Upper Tract Urothelial Carcinoma. Upper urinary tract t 4
ABTECT-2 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -2 Not authorised

2022-500536-11-00 Moderately to severely active ulcerative colitis 5
ABTECT-Maintenance – ABX464 Treatment Evaluation for ulcerative Colitis Therapy Not authorised

2022-500537-84-00 Moderately to severely active ulcerative colitis 5
A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovasc… Unknown

2022-502779-40-99 Primary prevention of atherosclerotic cardiovascular di 5
Phase 2 Study of Momelotinib in Combination with Luspatercept in Participants with Transfusion Dependent Myelofibrosis. Pending

2024-518225-15-00 Myelofibrosis 4
OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending

2025-520554-11-00 Cardiovascular Disease 5
In vivo biological standardization of Blomia tropicalis allergen extract. Pending

2025-520711-14-00 Allergies 4
Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with … Pending

2025-521086-28-00 CHRONIC INFLAMMATORY RHEUMATIC DISEASE: rheumatoid arth 6
Safety and efficacy of treatment combination with ponatinib and asciminib in chronic myeloid leukemia patients resistant to ponatinib and/or… Pending

2025-521126-15-00 Chronic Myeloid Leukemia 4
Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad… Pending

2025-521221-32-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5
A clinical trial to evaluate the efficacy and safety of a mixture of allergenic extracts of D. pteronyssinus and D. farinae, in patients suf… Pending

2025-521230-29-00 Allergic rhinoconjunctivitis to Dermatophagoides pteron 5
REstoration with calcifediol of VItamin D deficiency in pulmonary Arterial Hypertension patients (REVIDAH study) Pending

2025-521694-14-00 Patients with diagnosis of Pulmonary Arterial Hypertens 6
Phase 1/2 multicenter, two-arms, open-label, dose-escalation study of IDP-121 in combination with chemotherapy in patients with relapsed sma… Pending

2025-521902-17-00 Unresectable/metastatic Small cell Lung Cancer (SCLC) 9
Clinical trial to assess the efficacy and safety of a vaccine for dust mite and Blomia tropicalis allergy. Pending

2025-522773-12-00 Aetiological treatment of moderate-to-severe allergic r 5
A study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia… Pending

2025-523238-17-00 Acute myeloid leukemia 4
A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden… Pending

2025-523259-72-00 Hidradenitis Suppurativa (HS) 5
A study of pelabresib and ruxolitinib compared to placebo and ruxolitinib in adult patients with myelofibrosis who have not received prior t… Pending

2025-523555-66-00 Myelofibrosis 5
Efficacy and safety of vamifeport in adult subjects with HFE-related hereditary hemochromatosis Pending

2025-523793-16-00 Homeostatic iron regulator gene-related hereditary hemo 4
Phase 3 Study of Revumenib in Combination with Intensive Chemotherapy in Newly Diagnosed NPM1-mutated AML Recruiting

2025-522279-27-00 Newly Diagnosed AML with an NPM1 mutation 5 2026-04-02
Study for frail patients with newly diagnosed multiple myeloma treated with Daratumumab in combination with Teclistamab and Talquetamab. Recruiting

2024-520433-76-00 Newly Diagnosed Multiple Myeloma 4 2026-01-08
CLEOPATTRA: A research study to look at the effects of treatment with a medicine called coramitug (NNC6019-0001) in people with heart failur… Recruiting

2024-518899-31-00 Variant or wild-type transthyretin (TTR) amyloid cardio 5 2025-12-19
A Study to Evaluate the Long-term Safety and Effectiveness of APG777 in Subjects with Atopic Dermatitis Recruiting

2024-519795-11-00 Atopic Dermatitis 4 2025-10-06
Selective Treatment of Oral Povorcitinib Long-Term Rollover Study (STOP-LTR) Recruiting

2024-520107-12-00 Hidradenitis Suppurativa // Prurigo Nodularis // Vitili 5 2025-09-03
A Phase 3, Randomized, Open-Label Study of Axatilimab Versus Best Available Therapy in Participants With Chronic Graft-Versus-Host Disease A… Recruiting

2024-518973-32-00 Chronic Graft-Versus-Host Disease 5 2025-07-03